$0.17
0.00 (-0.52%)
Open$0.17
Previous Close$0.17
Day High$0.18
Day Low$0.17
52W High$33.66
52W Low—
Volume—
Avg Volume1.46M
Market Cap7.67M
P/E Ratio—
EPS$-0.20
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.61M | 6.76M | 8.11M |
| Net Income | 881.2K | 841.9K | 1.08M |
| Profit Margin | 11.6% | 12.5% | 13.3% |
| EBITDA | 1.17M | 1.13M | 1.25M |
| Free Cash Flow | 539.3K | 438.1K | 671.3K |
| Rev Growth | -2.4% | +10.1% | +12.1% |
| Debt/Equity | 0.23 | 0.23 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |